| Structure | Chemical Name | CAS | MF |
|
Pyrazino[1,2-a]indole, 6-ethyl-1,2,3,4,10,10a-hexahydro-4-methyl-, (4R,10aS)- (9CI)
|
396074-56-9
|
C14H20N2
|
|
Pyrazino[1,2-a]indole, 6-ethyl-1,2,3,4,10,10a-hexahydro-4-methyl-, (4R,10aR)- (9CI)
|
396074-62-7
|
C14H20N2
|
|
(5-Chloro-2-fluorophenyl)hydrazine
|
396074-99-0
|
C6H6ClFN2
|
|
(3-chloro-2-fluorophenyl)hydrazine
|
396075-11-9
|
C6H6ClFN2
|
|
3-Fluoro-2-methyl-phenyl-hydrazine
|
396075-80-2
|
C7H9FN2
|
|
7-(Trifluoromethoxy)-1H-indole
|
396075-91-5
|
C9H6F3NO
|
|
7-bromo-5-fluoro-1H-indole-2-carboxylic acid ethyl ester
|
396076-60-1
|
C11H9BrFNO2
|
|
H-Ala-Pro-Val-5-[(2-aminoethyl)amino]-naphthalene-1-sulfonic acid
|
396077-59-1
|
C25H35N5O6S
|
|
4-Isopropyl benzyl 5-aminolevulinate hydrochloride
|
396078-69-6
|
C15H23ClNO3
|
|
4-Methyl benzyl 5-aminolevulinate hydrochloride
|
396078-70-9
|
C13H19ClNO3
|
|
4-Methyl pentyl aminolevulinate hydrochloride
|
396078-72-1
|
C11H22ClNO3
|
|
4-Trifluoromethyl benzyl 5-aminolevulinate hydrochloride
|
396078-73-2
|
C13H16ClF3NO3
|
|
4-tert-Butyl benzyl 5-aminolevulinate hydrochloride
|
396078-74-3
|
C16H25ClNO3
|
|
4-Nitro benzyl 5-aminolevulinate hydrochloride
|
396078-75-4
|
C12H15ClN2O5
|
|
1-Ethylbutyl 5-aminolevulinate hydrochloride ester
|
396078-76-5
|
C11H22ClNO3
|
|
2-Methyl pentyl aminolevulinate hydrochloride
|
396078-77-6
|
C11H21NO3.ClH
|
|
3-Di-methylbutyl aminolevulinate hydrochloride ester
|
396078-80-1
|
C11H22ClNO3
|
|
4-Chlorobenzyl 5-aminolevulinate hydrochloride ester
|
396078-83-4
|
C12H15Cl2NO3
|
|
3-Nitro benzyl 5-aminolevulinate hydrochloride
|
396078-84-5
|
C12H15ClN2O5
|
|
2-Methyl benzyl 5-aminolevulinate hydrochloride
|
396078-91-4
|
C13H17NO3.ClH
|
|
3-Methyl benzyl 5-aminolevulinate hydrochloride
|
396078-93-6
|
C13H17NO3.ClH
|
|
Benzeneethanethiol, 3-ethoxy-4-methoxy- (9CI)
|
396088-09-8
|
C11H16O2S
|
|
1H-Pyrrole-2,5-dione, 3-[3-[(2,3-dihydroxypropyl)amino]phenyl]-4-(5-fluoro-1-methyl-1H-indol-3-yl)-
|
396091-16-0
|
C22H20FN3O4
|
|
1H-Indole,5-(1-methylethoxy)-(9CI)
|
396091-50-2
|
C11H13NO
|
|
Pasireotide
|
396091-73-9
|
C58H66N10O9
|
|
Pasireotide (for the salt)
|
396091-77-3
|
C62H73N11O13
|
|
2,3,4-Furantriol, tetrahydro-3-(hydroxymethyl)-, (3R,4R)- (9CI)
|
396092-72-1
|
C5H10O5
|
|
2-Bromo-4-dimethylaminopyridine
|
396092-82-3
|
C7H9BrN2
|
|
2-Iodo-4-dimethylaminopyridine
|
396092-83-4
|
C7H9IN2
|
|
4-N,N-Dimethylamino-2-(tributylstannyl)-pyridine
|
396092-84-5
|
C19H36N2Sn
|
|
6-Bromo-4-N,N-dimethylamino-2,2'-bipyridine
|
396092-86-7
|
C12H12BrN3
|
|
Abz-Glu-Thr-Leu-Phe-Gln-Gly-Pro-Val-p-nitro-Phe-NH2
|
396096-53-0
|
C57H77N13O16
|
|
4-[(8-ethoxy-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinolin-1-ylidene)amino]-N-(2-pyrimidinyl)benzenesulfonamide
|
396099-26-6
|
C24H23N5O3S3
|
|
[5-(2,4-dichlorophenyl)furan-2-yl](morpholin-4-yl)methanone
|
396101-92-1
|
C15H13Cl2NO3
|
|
(2,3-dimethoxy-5-methylphenyl)boronic acid(SALTDATA: FREE)
|
396102-17-3
|
C9H13BO4
|
|
2-Cyclopenten-1-one,3-[(4-ethoxyphenyl)amino]-(9CI)
|
396104-41-9
|
C13H15NO2
|
|
4-(4-Benzyl-1,4-diazepan-1-yl)-4-oxobutanoicacid
|
396105-43-4
|
C16H22N2O3
|
|
2-(Chloromethyl)-1H-imidazole hydrochloride
|
396105-96-7
|
C13H15NO5S
|
|
2-[2-[2-(2-Chloroethoxy)ethoxy]ethoxy]acetic Acid
|
396106-50-6
|
C8H15ClO5
|
|
(3-acetyl-2-methyl-5-phenyl-1H-pyrrol-1-yl)acetic acid
|
396123-23-2
|
C15H15NO3
|
|
3-(3-acetyl-2-methyl-5-phenyl-1H-pyrrol-1-yl)propanoic acid
|
396123-28-7
|
C16H17NO3
|
|
LY-364947
|
396129-53-6
|
C17H12N4
|
|
4-{3-[4-(Trifluoromethyl)phenyl]-1H-pyrazol-4-yl}pyridine
|
396129-66-1
|
C15H10F3N3
|
|
3-Thiazolidineacetic acid, 4-oxo--alpha--phenyl-
|
396129-91-2
|
C11H11NO3S
|
|
1-Piperidineacetic acid, 2-oxo--alpha--phenyl-
|
396129-93-4
|
C13H15NO3
|
|
(3-Cyanomethylphenyl)boronic acid, pinacol ester
|
396131-82-1
|
C14H18BNO2
|
|
3-Pyrrolidinamine,5-methyl-(9CI)
|
396133-22-5
|
C5H12N2
|
|
4-Piperidinamine,N,N,3-trimethyl-(9CI)
|
396133-23-6
|
C8H18N2
|
|
2-Pyrrolidinamine,5-methyl-(9CI)
|
396133-24-7
|
C5H12N2
|
|
Piperazine, 1,2,2-trimethyl- (9CI)
|
396133-32-7
|
C7H16N2
|
|
4,5,6,7-tetrahydro-1-phenyl-1H-pyrazolo[4,3-c]pyridine
|
396133-34-9
|
C12H13N3
|
|
4-PiperidinaMine, 3-Methyl-
|
396133-35-0
|
C6H14N2
|
|
4-Piperidinamine,3,3-dimethyl-(9CI)
|
396133-38-3
|
C7H16N2
|
|
4-Piperidinamine,3-ethyl-(9CI)
|
396133-40-7
|
C7H16N2
|
|
N-cyclopropylpiperidin-4-amine
|
396133-55-4
|
C8H16N2
|
|
R-5,5',6,6',7,7',8,8'-octahydro-3,3'-diphenyl-[1,1'-Binaphthalene]-2,2'-diol
|
396134-73-9
|
C32H30O2
|
|
2,4-Imidazolidinedione,1-ethyl-5-imino-(9CI)
|
396639-40-0
|
C5H7N3O2
|
|
Ethanone,1-(2-ethyl-3,6-dihydroxy-4,5-dimethylphenyl)-(9CI)
|
396639-83-1
|
C12H16O3
|
|
Methyl 1-methyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazole-5-carboxylate
|
396652-38-3
|
C10H10N2O3
|
|
Methyl 4-(ethylaMino)-3-nitrobenzoate
|
396652-42-9
|
C10H12N2O4
|
|
Benzoic acid, 2-amino-5-fluoro-, methyl ester, hydrochloride
|
396652-66-7
|
C8H9ClFNO2
|
|
tert-butyl 1,1-dichloro-2-oxo-7-azaspiro[3.5]nonane-7-carboxylate
|
396653-31-9
|
C13H19Cl2NO3
|
|
Bicyclo[3.1.0]hex-3-en-2-one, 4,5,6,6-tetramethyl-, (-)- (9CI)
|
396665-47-7
|
C10H14O
|
|
Bicyclo[3.1.0]hex-3-en-2-one, 4,5,6,6-tetramethyl-, (+)- (9CI)
|
396665-48-8
|
C10H14O
|
|
1-Acetyl-N-(1-benzylpiperidin-4-yl)-indolin-6-amine
|
396682-63-6
|
C22H27N3O
|
|
4-(1,7-Naphthyridin-8-ylamino)-4-oxobutanoicacid
|
396682-90-9
|
C12H11N3O3
|
|
2,3-Diazabicyclo[2.2.2]oct-2-ene-1-methanamine(9CI)
|
396715-58-5
|
C7H13N3
|
|
N-Me-abz-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2
|
396716-07-7
|
C51H79N17O13
|
|
DABCYL-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-EDANS
|
396716-14-6
|
C70H104N22O18S
|
|
1-Bromo-1,3,3,3-tetrafluoroprop-1-ene
|
396716-42-0
|
C3HBrF4
|
|
2-Bromo-1,3,3,3-tetrafluoropropene
|
396716-43-1
|
C3HBrF4
|
|
1,2-Dibromopentafluoropropyl 2,2,3,3,3-pentafluoropropyl ether
|
396716-50-0
|
C6H2Br2F10O
|
|
1,2-Dibromopentafluoropropyl 2,2,3,3-tetrafluoropropyl ether
|
396716-51-1
|
C6H3Br2F9O
|
|
1,2-Dibromopentafluoropropyl 2,2,2-trifluoroethyl ether
|
396716-52-2
|
C5H2Br2F8O
|
|
Benzaldehyde, 2-(3-hydroxy-1-propynyl)- (9CI)
|
396717-19-4
|
C10H8O2
|
|
4-Isoquinolin-3-yl-butyronitrile
|
396717-24-1
|
C13H12N2
|
|
Asn-Arg-Cys-Ser-Gln-Gly-Ser-Cys-Trp-Asn
|
396717-30-9
|
C44H65N17O16S2
|
|
MCA-Pro-Lys-Pro-Leu-Ala-Leu-Dap(Dnp)-Ala-Arg-NH2
|
396717-35-4
|
C61H89N17O17
|
|
4-Methoxyphenylazoformyl-Phe potassium salt
|
396717-86-5
|
C17H17N3O4.K
|
|
MCA-Arg-Pro-Lys-Pro-Gln-OH
|
396718-26-6
|
C39H56N10O11
|
|
Thiocarbonic acid O-tert-butyl ester S-(4-formyl-phenyl) ester
|
396725-68-1
|
C12H14O3S
|
|
Thiocarbonic acid O-tert-butyl ester S-(3-formyl-phenyl) ester
|
396725-72-7
|
C12H14O3S
|
|
HDMAPP - 1-Hydroxy-2-Methyl-2-buten-4-yl 4-diphosphate
|
396726-03-7
|
C5H12O8P2
|
|
Dnp-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-NH2
|
396726-42-4
|
C57H94N22O21
|
|
1,6-Diazabicyclo[3.2.1]octan-7-one, 6-acetyl- (9CI)
|
396730-26-0
|
C8H12N2O2
|
|
1,6-Diazabicyclo[3.2.1]octan-7-one,6-hydroxy-(9CI)
|
396730-33-9
|
C6H10N2O2
|
|
6-Oxa-1-azabicyclo[3.2.1]oct-3-en-7-one(9CI)
|
396730-54-4
|
C6H7NO2
|
|
1,2,3,6-Tetrahydro-pyridin-3-ol hydrochloride
|
396730-55-5
|
C5H10ClNO
|
|
(2S,5S)-2-allyl 1-tert-butyl 5-hydroxypiperidine-1,2-dicarboxylate
|
396731-09-2
|
C14H23NO5
|
|
3,5-Dioxo-piperidine-1-carboxylicacidtert-butylester
|
396731-40-1
|
C10H15NO4
|
|
3-(dimethylcarbamoyl)benzene-1-sulfonyl chloride
|
396733-71-4
|
C9H10ClNO3S
|
|
DIFOPEIN
|
396834-58-5
|
C273H424N76O89S6
|
|
4-Oxo-4-(5-oxo-1,4-diazepan-1-yl)butanoicacid
|
397244-77-8
|
C9H14N2O4
|
|
1-(2,6-Dimethoxybenzyl)piperidin-4-one
|
397244-87-0
|
C14H19NO3
|
|
1-(2,6-Dimethoxybenzyl)-N-methylpiperidine-4-amine
|
397244-99-4
|
C15H24N2O2
|
|
2-Aminoisophthalic acid
|
397245-00-0
|
C15H24N2O2
|
|
7-{[(4-Methoxyphenyl)sulfonyl]amino}-1H-indole-2-carboxylicacid
|
397245-05-5
|
C16H14N2O5S
|
|
(R)-2-tert-Butyloxycarbonylamino-pentane-1,5-diol
|
397246-12-7
|
C10H21NO4
|
|
(R)-(+)-2-(Boc-Amino)-1,4-butanediol
|
397246-14-9
|
C9H19NO4
|
|
Methyloxiran Polymer mit Oxiranhexandioatditetradecylether (2:1), mittlere Molmasse 10 g/mol, 2 mol PO und 10 mol EO
|
397247-05-1
|
C44H86O8
|